<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35579205</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5126</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>20</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of the American Chemical Society</Title><ISOAbbreviation>J Am Chem Soc</ISOAbbreviation></Journal><ArticleTitle>Amyloidogenesis of SARS-CoV-2 Spike Protein.</ArticleTitle><Pagination><StartPage>8945</StartPage><EndPage>8950</EndPage><MedlinePgn>8945-8950</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/jacs.2c03925</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection is associated with a surprising number of morbidities. Uncanny similarities with amyloid-disease associated blood coagulation and fibrinolytic disturbances together with neurologic and cardiac problems led us to investigate the amyloidogenicity of the SARS-CoV-2 spike protein (S-protein). Amyloid fibril assays of peptide library mixtures and theoretical predictions identified seven amyloidogenic sequences within the S-protein. All seven peptides in isolation formed aggregates during incubation at 37 &#xb0;C. Three 20-amino acid long synthetic spike peptides (sequence 192-211, 601-620, 1166-1185) fulfilled three amyloid fibril criteria: nucleation dependent polymerization kinetics by ThT, Congo red positivity, and ultrastructural fibrillar morphology. Full-length folded S-protein did not form amyloid fibrils, but amyloid-like fibrils with evident branching were formed during 24 h of S-protein coincubation with the protease neutrophil elastase (NE) <i>in vitro</i>. NE efficiently cleaved S-protein, rendering exposure of amyloidogenic segments and accumulation of the amyloidogenic peptide 194-203, part of the most amyloidogenic synthetic spike peptide. NE is overexpressed at inflamed sites of viral infection. Our data propose a molecular mechanism for potential amyloidogenesis of SARS-CoV-2 S-protein in humans facilitated by endoproteolysis. The prospective of S-protein amyloidogenesis in COVID-19 disease associated pathogenesis can be important in understanding the disease and long COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nystr&#xf6;m</LastName><ForeName>Sofie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4303-4783</Identifier><AffiliationInfo><Affiliation>Department of Physics, Chemistry and Biology, Link&#xf6;ping University, 58183 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammarstr&#xf6;m</LastName><ForeName>Per</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5827-3587</Identifier><AffiliationInfo><Affiliation>Department of Physics, Chemistry and Biology, Link&#xf6;ping University, 58183 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Chem Soc</MedlineTA><NlmUniqueID>7503056</NlmUniqueID><ISSNLinking>0002-7863</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.37</RegistryNumber><NameOfSubstance UI="D019272">Leukocyte Elastase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="Y">Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019272" MajorTopicYN="N">Leukocyte Elastase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare
no
competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35579205</ArticleId><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="doi">10.1021/jacs.2c03925</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walls A. C.; Park Y. J.; Tortorici M. A.; Wall A.; McGuire A. T.; Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 2020, 181 (2), 281&#x2013;292. 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.; Wang Y.; Li X.; Ren L.; Zhao J.; Hu Y.; Zhang L.; Fan G.; Xu J.; Gu X.; Cheng Z.; Yu T.; Xia J.; Wei Y.; Wu W.; Xie X.; Yin W.; Li H.; Liu M.; Xiao Y.; Gao H.; Guo L.; Xie J.; Wang G.; Jiang R.; Gao Z.; Jin Q.; Wang J.; Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395 (10223), 497&#x2013;506. 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipcsey M.; Persson B.; Eriksson O.; Blom A. M.; Fromell K.; Hultstrom M.; Huber-Lang M.; Ekdahl K. N.; Frithiof R.; Nilsson B. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. Front Immunol 2021, 12, 627579.10.3389/fimmu.2021.627579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.627579</ArticleId><ArticleId IdType="pmc">PMC7937878</ArticleId><ArticleId IdType="pubmed">33692801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y. M.; Xu G.; Wang B.; Liu B. C. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J. Intern Med. 2021, 289 (2), 147&#x2013;161. 10.1111/joim.13144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13144</ArticleId><ArticleId IdType="pmc">PMC7404514</ArticleId><ArticleId IdType="pubmed">32696489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha N.; Thakur A. K. Likelihood of amyloid formation in COVID-19-induced ARDS. Trends Microbiol 2021, 29 (11), 967&#x2013;969. 10.1016/j.tim.2021.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC8007089</ArticleId><ArticleId IdType="pubmed">33795156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavassoly O.; Safavi F.; Tavassoly I. Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection. ACS Chem. Neurosci. 2020, 11 (22), 3704&#x2013;3706. 10.1021/acschemneuro.0c00676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00676</ArticleId><ArticleId IdType="pubmed">33147014</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L. M.; Venter C.; Vlok M.; Ngoepe M.; Laubscher G. J.; Lourens P. J.; Steenkamp J.; Kell Douglas B.; Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. 2021, 41 (8), BSR20210611.10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouma B.; Maas C.; Hazenberg B. P.; Lokhorst H. M.; Gebbink M. F. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses. J. Thromb Haemost 2007, 5 (6), 1139&#x2013;42. 10.1111/j.1538-7836.2007.02457.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02457.x</ArticleId><ArticleId IdType="pubmed">17371485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammarstrom P. The bloody path of amyloids and prions. J. Thromb Haemost 2007, 5 (6), 1136&#x2013;8. 10.1111/j.1538-7836.2007.02575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02575.x</ArticleId><ArticleId IdType="pubmed">17567445</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas C.; Govers-Riemslag J. W.; Bouma B.; Schiks B.; Hazenberg B. P.; Lokhorst H. M.; Hammarstrom P.; ten Cate H.; de Groot P. G.; Bouma B. N.; Gebbink M. F. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J. Clin. Invest. 2008, 118 (9), 3208&#x2013;18. 10.1172/JCI35424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI35424</ArticleId><ArticleId IdType="pmc">PMC2518075</ArticleId><ArticleId IdType="pubmed">18725990</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch J.; Rucker E.; Standker L.; Adermann K.; Goffinet C.; Schindler M.; Wildum S.; Chinnadurai R.; Rajan D.; Specht A.; Gimenez-Gallego G.; Sanchez P. C.; Fowler D. M.; Koulov A.; Kelly J. W.; Mothes W.; Grivel J. C.; Margolis L.; Keppler O. T.; Forssmann W. G.; Kirchhoff F. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131 (6), 1059&#x2013;71. 10.1016/j.cell.2007.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.014</ArticleId><ArticleId IdType="pubmed">18083097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayeb-Fligelman E.; Cheng X.; Tai C.; Bowler J. T.; Griner S.; Sawaya M. R.; Seidler P. M.; Jiang Y. X.; Lu J.; Rosenberg G. M.; Salwinski L.; Abskharon R.; Zee C. T.; Hou K.; Li Y.; Boyer D. R.; Murray K. A.; Falcon G.; Anderson D. H.; Cascio D.; Saelices L.; Damoiseaux R.; Guo F.; Eisenberg D. S., Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2. bioRxiv, March 18, 2021, ver. 1. 10.1101/2021.03.05.434000v2 (accessed 2022-03-09).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.05.434000v2</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels E.; Rousseau F.; Schymkowitz J. Mechanisms and therapeutic potential of interactions between human amyloids and viruses. Cellular and molecular life sciences: CMLS 2021, 78 (6), 2485&#x2013;2501. 10.1007/s00018-020-03711-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03711-8</ArticleId><ArticleId IdType="pmc">PMC7690653</ArticleId><ArticleId IdType="pubmed">33244624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S. M.; Liao Y.; Neo T. L.; Lu Y.; Liu D. X.; Vahlne A.; Tam J. P. Identification and application of self-binding zipper-like sequences in SARS-CoV spike protein. international journal of biochemistry &amp; cell biology 2018, 101, 103&#x2013;112. 10.1016/j.biocel.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2018.05.012</ArticleId><ArticleId IdType="pmc">PMC7108413</ArticleId><ArticleId IdType="pubmed">29800727</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D.; Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochemical and biophysical research communications 2021, 554, 94&#x2013;98. 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer-Stroh S.; Debulpaep M.; Kuemmerer N.; Lopez de la Paz M.; Martins I. C.; Reumers J.; Morris K. L.; Copland A.; Serpell L.; Serrano L.; Schymkowitz J. W.; Rousseau F. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 2010, 7 (3), 237&#x2013;42. 10.1038/nmeth.1432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1432</ArticleId><ArticleId IdType="pubmed">20154676</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay V.; Lucas A.; Panja S.; Miyauchi R.; Mallela K. M. G. Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants. J. Biol. Chem. 2021, 297 (4), 101208.10.1016/j.jbc.2021.101208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101208</ArticleId><ArticleId IdType="pmc">PMC8445900</ArticleId><ArticleId IdType="pubmed">34543625</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson M. D.; Buxbaum J. N.; Eisenberg D. S.; Merlini G.; Saraiva M. J. M.; Sekijima Y.; Sipe J. D.; Westermark P. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 2020, 27 (4), 217&#x2013;222. 10.1080/13506129.2020.1835263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2020.1835263</ArticleId><ArticleId IdType="pubmed">33100054</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipe J. D.Amyloid proteins: the beta sheet conformation and disease; Wiley-VCH: Weinheim, 2005.</Citation></Reference><Reference><Citation>Peacock T. P.; Goldhill D. H.; Zhou J.; Baillon L.; Frise R.; Swann O. C.; Kugathasan R.; Penn R.; Brown J. C.; Sanchez-David R. Y.; Braga L.; Williamson M. K.; Hassard J. A.; Staller E.; Hanley B.; Osborn M.; Giacca M.; Davidson A. D.; Matthews D. A.; Barclay W. S. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nature microbiology 2021, 6 (7), 899&#x2013;909. 10.1038/s41564-021-00908-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00908-w</ArticleId><ArticleId IdType="pubmed">33907312</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson C.; Kirsebom F. C. M. Neutrophils in respiratory viral infections. Mucosal immunology 2021, 14 (4), 815&#x2013;827. 10.1038/s41385-021-00397-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00397-4</ArticleId><ArticleId IdType="pmc">PMC7985581</ArticleId><ArticleId IdType="pubmed">33758367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey K. C.; De S.; Mishra P. K. Role of Proteases in Chronic Obstructive Pulmonary Disease. Front. Pharmacol. 2017, 8, 512.10.3389/fphar.2017.00512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00512</ArticleId><ArticleId IdType="pmc">PMC5550664</ArticleId><ArticleId IdType="pubmed">28848433</ArticleId></ArticleIdList></Reference><Reference><Citation>Strnad P.; McElvaney N. G.; Lomas D. A. Alpha1-Antitrypsin Deficiency. N Engl J. Med. 2020, 382 (15), 1443&#x2013;1455. 10.1056/NEJMra1910234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1910234</ArticleId><ArticleId IdType="pubmed">32268028</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards R. J.; Mansouri K.; Stalls V.; Manne K.; Watts B.; Parks R.; Janowska K.; Gobeil S. M. C.; Kopp M.; Li D.; Lu X.; Mu Z.; Deyton M.; Oguin T. H. 3rd; Sprenz J.; Williams W.; Saunders K. O.; Montefiori D.; Sempowski G. D.; Henderson R.; Munir Alam S.; Haynes B. F.; Acharya P. Cold sensitivity of the SARS-CoV-2 spike ectodomain. Nat. Struct Mol. Biol. 2021, 28 (2), 128&#x2013;131. 10.1038/s41594-020-00547-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00547-5</ArticleId><ArticleId IdType="pmc">PMC7878407</ArticleId><ArticleId IdType="pubmed">33402708</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R.; Sorgjerd K.; Nystrom S.; Nordigarden A.; Yu Y. C.; Hammarstrom P. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. J. Mol. Biol. 2007, 366 (3), 1029&#x2013;44. 10.1016/j.jmb.2006.11.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2006.11.084</ArticleId><ArticleId IdType="pubmed">17196616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D. B.; Laubscher G. J.; Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem. J. 2022, 479 (4), 537&#x2013;559. 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasawa F.; Kani S.; Hongo M.; Okumura N. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I. Thromb Res. 2006, 118 (5), 651&#x2013;61. 10.1016/j.thromres.2005.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2005.10.013</ArticleId><ArticleId IdType="pubmed">16412498</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W.; Kuss O.; Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia 2022, 65, 949&#x2013;954. 10.1007/s00125-022-05670-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05670-0</ArticleId><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett C. E.; Koyama A. K.; Alvarez P.; Chow W.; Lundeen E. A.; Perrine C. G.; Pavkov M. E.; Rolka D. B.; Wiltz J. L.; Bull-Otterson L.; Gray S.; Boehmer T. K.; Gundlapalli A. V.; Siegel D. A.; Kompaniyets L.; Goodman A. B.; Mahon B. E.; Tauxe R. V.; Remley K.; Saydah S. Risk for Newly Diagnosed Diabetes &gt; 30 Days After SARS-CoV-2 Infection Among Persons Aged &lt; 18 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep 2022, 71 (2), 59&#x2013;65. 10.15585/mmwr.mm7102e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e2</ArticleId><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>